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3. Using fluoroscopic semi-flexed x-ray technique of Buckland- 
Wright, baseline and exit knee radiographs were digitised by laser 
scanner. Based upon computerized measurement of minimum 
medial compartment JSW, each group was subdivided into those 
with non-progressive or progressive joint space narrowing (JSN), 
viz. JSN _>0.6 mm at any point post-baseline (placebo n=l 1 ; 5mg 
n=16; 15mg n=21; 50mg n=17). The complement of this group 
forms the non-progressors. A region of interest (3/4 width of tib- 
ial compartment x 6mm height) was selected in the medial com- 
partment. Computerised method of Fractal Signature Analysis 
(FSA) quantified longitudinal changes in number and thickness 
(Buckland-Wright et al. Calcif Tissue Int 1994;54:106-12) sepa- 
rately in horizontal and vertical trabecular organisation in all study 
knees. 
Results: Over the study period, most knees had a slight de- 
crease in FSA of vertical and horizontal trabeculae (size range: 
0.18 to 1.14 mm), consistent with a modest decrease in tra- 
becular number. However, compared to the non-progressor JSN 
group the degree of bone loss was substantially greater in knees 
with progressive JSN (p<0.05) in both placebo and 5mg groups 
for vertical (placebo, sizes: 0.72-0.84mm, 1.14mm), (5mg, size: 
0.54mm) and horizontal (5mg, sizes: 0.30-0.66mm) trabeculae 
respectively, than those in 15mg and 50mg groups. In the lat- 
ter, the progressive JSN group did not show trabecular loss apart 
from mild horizontal trabeculae change within the 15mg group 
(sizes: 0.36-0.42mm, 0.72-0.90mm) only. 
Conclusion: In knee OA high doses of risedronate reduced the 
loss of trabecular structure within the subarticular egion of the 
medial diseased compartment. In contrast, patients with progres- 
sive JSN administered placebo or 5mg risedronate did not show 
a trabecular bone benefit in this highly aggressive disease sub- 
set. Thus, despite progressive cartilage loss, higher doses of rise- 
dronate protected joints against aggressive trabecular bone loss, 
thereby preserving its structural integrity, delaying the onset of 
compartmental collapse and potentially the requirement for knee 
arthroplasty. 
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Background: Type II collagen (CII) is the most abundant pro- 
tein of cartilage matrix. The synthesis and degradation of CII can 
be assessed by measuring the serum concentration of the N- 
propeptide of collagen type IIA (PIIANP) and the urinary excre- 
tion of crosslinked C-telopeptide (CTX-II), respectively. Previous 
short-term studies in advanced OA have shown that baseline lev- 
els of serum PIIANP and CTX-II were associated with disease 
progression. The aim of this study was to investigate the longi- 
tudinal changes of serum PIIANP and urinary CTX-II and their 
relationships with radiological progression in patients with early 
OA followed prospectively for 5 years. 
Patients and methods: Eighty four patients with persistent pain 
(>3 months) in one or both knees were included (54% female, 
mean age; 62 yr; 39% presenting a Kellgren-Lawrence score <2). 
We measured PIIANP and CTX-II using specific ELISAs at base- 
line, 2 yr, 3 yr and 5 yr and knee radiographs were obtained at 
baseline and 5 years. Disease progression was defined as either 
a reduction in the tibiofemoral joint space by at least 2 mm or total 
knee replacement at either knee during the 5-year follow-up. 
Results: During the 5 yr of the study there was a slight but sig- 
nificant increase of PIIANP (mean: 1.6%/yr, p<0.0001 ), whereas 
urinary CTX-II remained stable. Both serum PIIANP and urinary 
CTX-II were significantly higher throughout he study in the 24 
progressors compared to the 60 non progressors (p <0.05 for 
both by ANOVA). When patients were classified in quartile of 
mean-5yr levels of PIIANP or CTX-II, the increase in the risk of 
progression was observed in the highest quartile of PIIANP and 
for the two highest quartiles (above median) for CTX-II. The table 
below shows the odds-ratio, the sensitivity and specificity of pro- 
gression for patients with PIIANP in the highest quartile, CTX-II 
above the median or the combination of both markers. 
PIIANP alone CTX-II alone PIIANP+CTX-II 
Odds-ratio 3.2, p=O.O3 3.4, p=O.O2 11.8, p=O.OO2 
(95% CI) (1.1-9.0) (1.2-9.4) (2.5-54.5) 
Sensitivity (%) 42 71 92 
Sensitivity (%) 82 58 52 
Conclusion: In conclusion, in early knee OA, disease progres- 
sion is associated with increases of both synthesis and degrada- 
tion of type II collagen. Combination of serum PIIANP and urinary 
CTX-II may be useful to improve the identification of patients with 
early knee OA at high risk for rapid progression. 
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Purpose: As osteoarthritis (OA) is usually polyarticular, 
biomarker correlations with multiple, as opposed to single, joint 
radiologic scores are essential. We developed an assessment 
tool of OA burden (TQOL) using weighted scoring measures of 
large joint involvement, to correlate TQOL scores with biomark- 
ers of cartilage synthesis and degradation. 
Methods: X-rays and sera from 19 subjects (3 families in a hered- 
itary OA study); median age 34 years (range 12-70 yrs). X-rays of 
hands, hips and knees were read blind by 2 readers and scored 
for K-L grade 0-IV, and 0-111 (where grade 1 was considered 0 
to enhance linearity); osteophytes (OP) (0-3); joint space nar- 
rowing (JSN) (0-3); and sclerosis (0/1). Using MRI-derived car- 
tilage volumes from a normal control population, X-ray scores 
were weighted as follows: knee cartilage sagittal vol 22 ml or 
unicompartmental (UC) 11 ml; coronal weight-bearing 7 ml or 
UC 3.5 ml; hip total cartilage vol 9 ml; superior or medial-axial 
4.5 ml. Hand cartilage vol (approx. 2 ml) contributed minimally 
and was not included. TQOL scores were calculated for 4 large 
joints as: [(knee vols)(K-L grade, or JSN or sclerosis or OP) + 
(hip vols)(K-L grade or JSN or sclerosis or OP)]. Total cartilage 
vol at risk was 62 ml. Biomarkers included cartilage oligomeric 
protein (COMP), bone sialoprotein (BSP), neoepitope 846, type 
II collagen propeptide(C-II ProP) and 7H3 as measures of pro- 
teoglycan (PG) and collagen synthesis and degradation, bone 
synthesis and matrix turnover. Pearson correlation coefficients 
were calculated for each biomarker elated to the TQOL scores 
and also using only the radiographically worse knee to simulate 
single-joint-derived versus TQOL-derived calculations. 
Results: Significant correlations were found between neoepitope 
846 and C-II ProP, markers of PG and collagen synthesis respec- 
